Literature DB >> 1908026

The management of otolaryngological problems in the mucopolysaccharidoses: a retrospective review.

M J Ruckenstein1, R E Macdonald, J T Clarke, V Forte.   

Abstract

The mucopolysaccharidoses are rare, genetically transmitted metabolic disorders that affect children early in life. These potentially life-threatening diseases almost invariably involve the auditory apparatus and the upper respiratory tract. Thus, the otolaryngologist is frequently involved in the care of these patients. This paper presents a 10-year retrospective review of the management of these patients at the Hospital for Sick Children. Data concerning auditory and upper respiratory pathology are presented. Results indicate that persistent serous otitis, sensorineural hearing loss, and upper respiratory obstruction leading to sleep apnea, are frequent findings in these patients. Specific recommendations are made with regard to appropriate otolaryngologic intervention in children affected with these diseases.

Entities:  

Mesh:

Year:  1991        PMID: 1908026

Source DB:  PubMed          Journal:  J Otolaryngol        ISSN: 0381-6605


  6 in total

Review 1.  Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA.

Authors:  Hira Peracha; Kazuki Sawamoto; Lauren Averill; Heidi Kecskemethy; Mary Theroux; Mihir Thacker; Kyoko Nagao; Christian Pizarro; William Mackenzie; Hironori Kobayashi; Seiji Yamaguchi; Yasuyuki Suzuki; Kenji Orii; Tadao Orii; Toshiyuki Fukao; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2018-05-15       Impact factor: 4.797

2.  Audiometric evaluation in individuals with mucopolysaccharidosis.

Authors:  Marcela Rosana Maia da Silveira; Ana Karina Lima Buriti; Ana Maria Martins; Daniela Gil; Marisa Frasson de Azevedo
Journal:  Clinics (Sao Paulo)       Date:  2018-12-03       Impact factor: 2.365

3.  Hearing loss in patients with mucopolysaccharidoses-1 and -6 after hematopoietic cell transplantation: A longitudinal analysis.

Authors:  Brigitte T A van den Broek; Adriana L Smit; Jaap Jan Boelens; Peter M van Hasselt
Journal:  J Inherit Metab Dis       Date:  2020-07-09       Impact factor: 4.982

4.  Neurophysiology of hearing in patients with mucopolysaccharidosis type IV.

Authors:  Kyoko Nagao; Thierry Morlet; Elizabeth Haley; Jennifer Padilla; Julianne Nemith; Robert W Mason; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2018-02-08       Impact factor: 4.204

5.  Management of otolaryngological manifestations in mucopolysaccharidoses: our experience.

Authors:  M Mesolella; M Cimmino; E Cantone; A Marino; M Cozzolino; R Della Casa; G Parenti; M Iengo
Journal:  Acta Otorhinolaryngol Ital       Date:  2013-08       Impact factor: 2.124

6.  The impact of laronidase treatment in otolaryngological manifestations of patients with mucopolysaccharidosis.

Authors:  Ana Paula Fiuza Funicello Dualibi; Ana Maria Martins; Gustavo Antônio Moreira; Marisa Frasson de Azevedo; Reginaldo Raimundo Fujita; Shirley Shizue Nagata Pignatari
Journal:  Braz J Otorhinolaryngol       Date:  2015-12-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.